{"id":"W2898483684","doi":"10.1016/j.jtho.2018.08.961","title":"P1.15-28 Real World Treatment Patterns and Survival of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Gefitinib; Internal medicine; Erlotinib; Afatinib; Oncology; Stage (stratigraphy); Lung cancer; Cancer registry; Cohort; Population; Radiation therapy; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000503896,0.0003613642,0.0005696111,0.001208756,0.002999281,0.001632005,0.001498881,0.0005979306,0.004795506],"category_scores_gemma":[0.002257792,0.0004970694,0.0009872373,0.004570648,0.000822647,0.0004552731,0.0009837202,0.0008750716,0.0005813492],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04932997,"about_ca_system_score_gemma":0.06759383,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.99769,"about_ca_topic_score_gemma":0.9990436,"domain_scores_codex":[0.998938,0.00006931871,0.00008904213,0.0001688659,0.0002794431,0.0004552728],"domain_scores_gemma":[0.9963443,0.0001477588,0.0006398437,0.000105353,0.001657695,0.001105056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001269372,0.00002462831,0.9908764,0.00005824544,0.00007204455,0.0001214348,0.0005596763,0.0002250339,0.0001714976,0.0001940504,0.00468314,0.002886995],"study_design_scores_gemma":[0.00001628456,0.00002087367,0.9959581,0.00004975031,0.00003407007,0.00006365298,0.001188378,0.0002343931,0.00004785759,0.00003049894,0.002341995,0.00001415905],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9402797,0.001501702,0.0002420788,0.002126821,0.00007496533,0.0001386294,0.04596211,0.00004176522,0.009632205],"genre_scores_gemma":[0.9872531,0.0005592979,0.0002373103,0.0002530944,0.00001617269,0.00004162668,0.006870411,0.00002376631,0.004745238],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04932997,"threshold_uncertainty_score":0.3579157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02186078006344266,"score_gpt":0.3933934851029597,"score_spread":0.3715327050395171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}